A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19.
Sandra JonmarkerJacob LitorellFelix AlarconKais Al-AbaniSofia BjörkmanMaria FarmJonathan GripMårten SöderbergJacob HollenbergRebecka Rubenson WahlinThomas KanderLiivi RimlingJohan MårtenssonEva Joelsson-AlmMartin DahlbergMaria CronhjortPublished in: Thrombosis journal (2023)
The study was retrospectively registered at Clinicaltrials.gov, NCT05256524, February 24, 2022.